Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 28, 1993 - Issue 3
Submit an article Journal homepage
77
Views
82
CrossRef citations to date
0
Altmetric
Original Article

Lansoprazole versus Omeprazole in Short-Term Treatment of Reflux Oesophagitis Results of a Scandinavian Multicentre Trial

J. G. Hatlebakk Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
A. Berstad Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
L. Carling Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
L. E. Svedberg Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
P. Unge Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
P. Ekström Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
L. Halvorsen Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
A. Stallemo Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
N. Hovdenak Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
R. Trondstad Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
,
E. Kittang Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
&
O. J. Lange Division of Gastroenterology, Dept. of Medicine, Haukeland University Hospital, Bergen; Dept. of Medicine, Rogaland Regional Hospital, Stavanger; Dept. of Medicine, Vest-Agder Central Hospital, Kristiansand; Dept. of Medicine, The Deaconess Hospital, Bergen; Dept. of Medicine, Møre og Romsdal Central Hospital, Ålesund; Dept. of Medicine, Vestfold Central Hospital, Tønsberg; Dept. of Medicine, Molde Hospital, Molde, Norway; Dept. of Medicine, Bollnäs Hospital, Bollnäs, Sandviken, Sweden; Depts. of Medicine and Surgery, Sandviken Hospital, Sandviken, Sweden
 show all
Pages 224-228 | Received 14 May 1992, Accepted 28 Sep 1992, Published online: 08 Jul 2009

Citations (82)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (7)

Ganta Madhusudhan Reddy, K. Mukkanti, T. Laxmi Kumar, J. Moses Babu & Padi Pratap Reddy. (2008) Synthesis and Characterization of Metabolites and Potential Impurities of Lansoprazole, an Antiulcerative Drug. Synthetic Communications 38:20, pages 3477-3489.
Read now
J. G. Hatlebakk & A. Berstad. (1997) Endoscopic Grading of Reflux Oesophagitis: What Observations Correlate with Gastro-Oesophageal Reflux?. Scandinavian Journal of Gastroenterology 32:8, pages 760-765.
Read now
J. G. Hatlebakk & A. Berstad. (1996) Gastro-Oesophageal Reflux during 3 Months of Therapy with Ranitidine in Reflux Oesophagitis. Scandinavian Journal of Gastroenterology 31:10, pages 954-958.
Read now
Andrew Garner & Tanzeel Ansari. (1996) Drug Evaluation: Pulmonary-Allergy, Dermatological, Gastrointestinal & Arthritis: Lansoprazole: A new proton pump inhibitor for the treatment of peptic ulceration and reflux oesophagitis. Expert Opinion on Investigational Drugs 5:1, pages 17-27.
Read now
J. G. Hatlebakk, L. B. Nesje, T. Hausken, C. J. Bang & A. Berstad. (1995) Lansoprazole Capsules and Amoxicillin Oral Suspension in the Treatment of Peptic Ulcer Disease. Scandinavian Journal of Gastroenterology 30:11, pages 1053-1057.
Read now
P. Ekström, L. Carling, P. Unge, O. Anker-Hansen, S. Sjöstedt & H. Sellström. (1995) Lansoprazole versus Omeprazole in Active Duodenal Ulcer a Double-Blind, Randomized, Comparative Study. Scandinavian Journal of Gastroenterology 30:3, pages 210-215.
Read now
A. Berstad & J. G. Hatlebakk. (1995) The Predictive Value of Symptoms in Gastro-oesophageal Reflux Disease. Scandinavian Journal of Gastroenterology 30:sup211, pages 1-4.
Read now

Articles from other publishers (75)

Sensen Yang, Weishang Deng, Zeyu Xie & Jisheng Chen. (2022) Efficacy and safety of proton pump inhibitors versus vonoprazan in treatment of erosive esophagitis: A PRISMA-compliant systematic review and network meta-analysis. Medicine 101:47, pages e31807.
Crossref
Cátia Santos-Pereira, María T. Andrés, José F. Fierro, Lígia R. Rodrigues & Manuela Côrte-Real. (2022) A review on lactoferrin as a proton pump inhibitor. International Journal of Biological Macromolecules 202, pages 309-317.
Crossref
Hirota Miyazaki, Ataru Igarashi, Toshihisa Takeuchi, Lida Teng, Akihito Uda, Hisato Deguchi, Kazuhide Higuchi & Toshiro Tango. (2019) Vonoprazan versus proton‐pump inhibitors for healing gastroesophageal reflux disease: A systematic review . Journal of Gastroenterology and Hepatology 34:8, pages 1316-1328.
Crossref
Mei-Juan Li, Qing Li, Min Sun & Li-Qin Liu. (2017) Comparative effectiveness and acceptability of the FDA-licensed proton pump inhibitors for erosive esophagitis. Medicine 96:39, pages e8120.
Crossref
José de Jesús González-Izquierdo, Tulio Jesús Hernandez-Aguilar, Ulises Rodrigo Palomares-Chacón, Luis Fernando Castelltor Hernandez, José Víctor Pérez Navarro & Roberto Anaya-Prado. (2015) Manejo actual de la enfermedad por reflujo gastroesofágico. Cirujano General.
Crossref
Roberto Anaya-Prado, José Víctor Pérez Navarro, Luis Fernando Castelltor Hernández, Ulises Rodrigo Palomares-Chacón, Tulio Jesús Hernández-Aguilar & José de Jesús González-Izquierdo. (2015) Tratamiento actual de la enfermedad por reflujo gastroesofágico. Cirujano General 37:1-2, pages 38-43.
Crossref
David Russell, Manjo Luthra, Liz Plastow, Ruth Airdrie & Martin Marshall. (2000) Cost-effective prescribing in general practice: Patients' attitudes to financially motivated prescribing changes. International Journal of Pharmacy Practice 8:1, pages 27-32.
Crossref
Paul Moayyedi, Jose Santana, Mostafiz Khan, Cathy Preston & Clare Donnellan. (2011) Medical treatments in the short term management of reflux oesophagitis. Cochrane Database of Systematic Reviews.
Crossref
Weijiang Zhang, Jingtao Wu & Stuart N. Atkinson. (2009) Effects of Dexlansoprazole MR, a Novel Dual Delayed Release Formulation of a Proton Pump Inhibitor, on Plasma Gastrin Levels in Healthy Subjects. The Journal of Clinical Pharmacology 49:4, pages 444-454.
Crossref
Jai Moo Shin & George Sachs. (2008) Pharmacology of proton pump inhibitors. Current Gastroenterology Reports 10:6, pages 528-534.
Crossref
Alan B. R. Thomson. (2007) Standard doses of the oral proton pump inhibitors are clinically equivalent: A comparison. Current GERD Reports 1:4, pages 223-232.
Crossref
Paul Moayyedi, Jose Santana, Mostafiz Khan, Cathy Preston & Clare Donnellan. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
G. A. COTÉ, M. R. FERREIRA, K. ROZENBERG-BEN-DROR & C. W. HOWDEN. (2007) Programme of stepping down from twice daily proton pump inhibitor therapy for symptomatic gastro-oesophageal reflux disease associated with a formulary change at a VA medical center. Alimentary Pharmacology & Therapeutics 25:6, pages 709-714.
Crossref
Masashi Kawamura, Shuichi Ohara, Tomoyuki Koike, Katsunori Iijima, Hitoshi Suzuki, Shoichi Kayaba, Kenji Noguchi, Shinya Abe, Mitsunori Noguchi & Toru Shimosegawa. (2007) Cytochrome P450 2C19 polymorphism influences the preventive effect of lansoprazole on the recurrence of erosive reflux esophagitis. Journal of Gastroenterology and Hepatology 22:2, pages 222-226.
Crossref
Ernst Eypasch, Edmund A.M. Neugebauer, F. Fischer, Hans Troidl, A.L. Blum, D. Collet, A. Cuschieri, B. Dallemagne, H. Feussner, K.-H. Fuchs, H. Glise, C.K. Kum, T. Lerut, L. Lundell, H.E. Myrvold, A. Peracchia, H. Petersen & J.J.B. van Lanschot. 2006. EAES Guidelines for Endoscopic Surgery. EAES Guidelines for Endoscopic Surgery 97 124 .
A. Bansal & P. Sharma. 2006. Gastroesophageal Reflux Disease. Gastroesophageal Reflux Disease 113 120 .
M. B. Fennerty, J. F. Johanson, C. Hwang & M. Sostek. (2005) Efficacy of esomeprazole 40 mg vs. lansoprazole 30 mg for healing moderate to severe erosive oesophagitis. Alimentary Pharmacology and Therapeutics 21:4, pages 455-463.
Crossref
Chih-Yen Chen. (2005) Esomeprazole tablet vs omeprazole capsule in treating erosive esophagitis . World Journal of Gastroenterology 11:20, pages 3112.
Crossref
K. Madan, V. Ahuja, P. C. Kashyap & M. P. Sharma. (2004) Comparison of efficacy of pantoprazole alone versus pantoprazole plus mosapride in therapy of gastroesophageal reflux disease: a randomized trial. Diseases of the Esophagus 17:4, pages 274-278.
Crossref
Naoki Chiba. 2004. Evidence‐based Gastroenterology and Hepatology. Evidence‐based Gastroenterology and Hepatology 13 54 .
Tommy Andersson. (2004) Single-Isomer Drugs. Clinical Pharmacokinetics 43:5, pages 279-285.
Crossref
David L. Whaley, Curtis M. Warren & David L. Thomas. (2004) Drug Switching: The Bottom Line Isn’t Always What It Seems. Journal of Correctional Health Care 10:2, pages 227-237.
Crossref
N. Vakil & M. B. Fennerty. (2003) Direct comparative trials of the efficacy of proton pump inhibitors in the management of gastro-oesophageal reflux disease and peptic ulcer disease. Alimentary Pharmacology & Therapeutics 18:6, pages 559-568.
Crossref
R. M. Klok, M. J. Postma, B. A. Van Hout & J. R. B. J. Brouwers. (2003) Meta-analysis: comparing the efficacy of proton pump inhibitors in short-term use. Alimentary Pharmacology & Therapeutics 17:10, pages 1237-1245.
Crossref
M. Kawamura, S. Ohara, T. Koike, K. Iijima, J. Suzuki, S. Kayaba, K. Noguchi, S. Hamada, M. Noguchi & T. Shimosegawa. (2003) The effects of lansoprazole on erosive reflux oesophagitis are influenced by CYP2C19 polymorphism. Alimentary Pharmacology & Therapeutics 17:7, pages 965-973.
Crossref
A Radi. (2002) Adsorptive stripping square-wave voltammetric study of the degradation of lansoprazole in aqueous solutions. Microchemical Journal 73:3, pages 349-354.
Crossref
M P Jones. (2002) Acid suppression in gastro-oesophageal reflux disease: Why? How? How much and when?. Postgraduate Medical Journal 78:922, pages 465-468.
Crossref
C. J. J. Mulder, B. D. Westerveld, J. M. Smit, M. Oudkerk Pool, M. H. Otten, T. G. Tan, A. W. M. van Milligen de Wit & G. H. de Groot. (2002) A double-blind, randomized comparison of omeprazole Multiple Unit Pellet System (MUPS) 20 mg, lansoprazole 30 mg and pantoprazole 40 mg in symptomatic reflux oesophagitis followed by 3 months of omeprazole MUPS maintenance treatment: a Dutch multicentre trial. European Journal of Gastroenterology & Hepatology 14:6, pages 649-656.
Crossref
RL Bown. (2002) AN OVERVIEW OF THE PHARMACOLOGY, EFFICACY, SAFETY AND COST‐EFFECTIVENESS OF LANSOPRAZOLE. International Journal of Clinical Practice 56:2, pages 132-139.
Crossref
Donald O. Castell, Peter J. Kahrilas, Joel E. Richter, Nimish B. Vakil, David A. Johnson, Seth Zuckerman, Wendy Skammer & Jeffrey G. Levine. (2002) Esomeprazole (40 mg) compared with lansoprazole (30 mg) in the treatment of erosive esophagitis. The American Journal of Gastroenterology 97:3, pages 575-583.
Crossref
Colin W. Howden, E. David BallardIIII & Weining Robieson. (2002) Evidence for Therapeutic Equivalence of Lansoprazole 30mg and Esomeprazole 40mg in the Treatment of Erosive Oesophagitis. Clinical Drug Investigation 22:2, pages 99-109.
Crossref
S. J. Edwards, T. Lind & L. Lundell. (2001) Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis. Alimentary Pharmacology & Therapeutics 15:11, pages 1729-1736.
Crossref
P. O. Katz, S. Xue & D. O. Castell. (2002) Control of intragastric pH with omeprazole 20 mg, omeprazole 40 mg and lansoprazole 30 mg. Alimentary Pharmacology & Therapeutics 15:5, pages 647-652.
Crossref
Solomon Tefera, Jan Gunnar Hatlebakk & Arnold Berstad. (2001) Stability of Gastric Secretory Inhibition During 6-Month Treatment With Omeprazole in Patients With Gastroesophageal Reflux Disease. American Journal of Gastroenterology 96:4, pages 969-974.
Crossref
V. K. Sharma, G. I. Leontiadis & C. W. Howden. (2008) Meta‐analysis of randomized controlled trials comparing standard clinical doses of omeprazole and lansoprazole in erosive oesophagitis. Alimentary Pharmacology & Therapeutics 15:2, pages 227-231.
Crossref
Jan G. Hatlebakk & Arnold Berstad. 2001. Barrett’s Esophagus. Barrett’s Esophagus 121 135 .
R. Fass, U. Murthy, C. W. Hayden, I. B. Malagon, G. Pulliam, C. Wendel & T. O. G. Kovacs. (2002) Omeprazole 40 mg once a day is equally effective as lansoprazole 30 mg twice a day in symptom control of patients with gastro‐oesophageal reflux disease (GERD) who are resistant to conventional‐dose lansoprazole therapy—a prospective, randomized, multi‐centre study. Alimentary Pharmacology & Therapeutics 14:12, pages 1595-1603.
Crossref
Alan B. R. Thomson. (2000) Are the orally administered proton pump inhibitors equivalent? A comparison of lansoprazole, omeprazole, pantoprazole, and rabeprazole. Current Gastroenterology Reports 2:6, pages 482-493.
Crossref
Peter J. Kahrilas. (2000) Strategies for medical management of reflux disease. Best Practice & Research Clinical Gastroenterology 14:5, pages 775-791.
Crossref
P. J. Kahrilas, G. W. Falk, D. A. Johnson, C. Schmitt, D. W. Collins, J. Whipple, D. D'Amico, B. Hamelin & B. Joelsson. (2001) Esomeprazole improves healing and symptom resolution as compared with omeprazole in reflux oesophagitis patients: a randomized controlled trial. Alimentary Pharmacology & Therapeutics 14:10, pages 1249-1258.
Crossref
C. A. M. Stedman & M. L. Barclay. (2001) Review article: comparison of the pharmacokinetics, acid suppression and efficacy of proton pump inhibitors. Alimentary Pharmacology & Therapeutics 14:8, pages 963-978.
Crossref
Ph. Houcke, D. Goldfain, P. Guyot, Th. Helbert, J. Laurent, J. F. Rey, D. Rouhier, J. Cassigneul, B. Marchetti, A. Papazian & M. Laurence. (2000) Prévention des récidives de l’oesophagite par reflux par le lansoprazole: 30 mg un jour sur deux ou 15 mg tous les jours?Prevention of relapse of gastro-oesophageal reflux disease by lansoprazole: 30 mg every other day or 15 mg daily?. Acta Endoscopica 30:3, pages 243-253.
Crossref
Gerson, Hatton, Ryono, Jones, Pulliam, Sampliner, Triadafilopoulos & Fass. (2001) Clinical and fiscal impact of lansoprazole intolerance in veterans with gastro‐oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 14:4, pages 397-406.
Crossref
Gustavo R. Heudebert, Robert M. Centor, Joshua C. Klapow, Robert Marks, Lawrence Johnson & C. Mel Wilcox. (2000) What is heartburn worth?. Journal of General Internal Medicine 15:3, pages 175-182.
Crossref
P. O. Katz. 2000. Helicobacter pylori. Helicobacter pylori 385 390 .
Edmund Neugebauer & Stefan Sauerland. 2000. Recommendations for evidence-based endoscopic surgery. Recommendations for evidence-based endoscopic surgery 47 62 .
Jansen & Van Oene. (2001) Standard‐dose lansoprazole is more effective than high‐dose ranitidine in achieving endoscopic healing and symptom relief in patients with moderately severe reflux oesophagitis. Alimentary Pharmacology & Therapeutics 13:12, pages 1611-1620.
Crossref
Jan G. Hatlebakk, Philip O. Katz & Donald O. Castell. (1999) MEDICAL THERAPY. Gastroenterology Clinics of North America 28:4, pages 847-860.
Crossref
Lorenzo G. Mantovani, A. Belisari & G. Dobrilla. (2013) Valutazione economica del lansoprazolo nel trattamento dei pazienti affetti da reflusso esofageo. PharmacoEconomics Italian Research Articles 1:1, pages 43-51.
Crossref
Wilhelmsen, Hatlebakk, Olafsson & Berstad. (2001) On demand therapy of reflux oesophagitis — a prospective study of symptoms, patient satisfaction and quality of life. Alimentary Pharmacology & Therapeutics 13:8, pages 1035-1040.
Crossref
Nuzhat A. Ahmad & David C. Metz. (1999) DYSPEPSIA AND HEARTBURN. Rheumatic Disease Clinics of North America 25:3, pages 703-718.
Crossref
Virender K Sharma, Rajeev Vasudeva & Colin W Howden. (1999) Simplified Lansoprazole Suspension— A Liquid Formulation of Lansoprazole— Effectively Suppresses Intragastric Acidity When Administered Through A Gastrostomy. American Journal of Gastroenterology 94:7, pages 1813-1817.
Crossref
Tefera, Hatlebakk & Berstad. (2001) The effect of Helicobacter pylori eradication on gastro‐oesophageal reflux . Alimentary Pharmacology & Therapeutics 13:7, pages 915-920.
Crossref
Nuran Özaltı́n. (1999) Determination of Lansoprazole in pharmaceutical dosage forms by two different spectroscopic methods. Journal of Pharmaceutical and Biomedical Analysis 20:3, pages 599-606.
Crossref
Nella Bieszk & Pramodini B Kale-Pradhan. (2016) The Efficacy of Extended-Interval Dosing of Omeprazole in Keeping Gastroesophageal Reflux Disease Patients Symptom Free. Annals of Pharmacotherapy 33:5, pages 638-641.
Crossref
Ch. Florent. (1999) Mise au point lansoprazole: pharmacocinétique, pharmacodynamique et activité thérapeutiqueLansoprazole: pharmacokinetic, pharmacodynamic and clinical efficacy: a review. Acta Endoscopica 29:2, pages 157-168.
Crossref
Yaning Hao, Xicai Sun & Jian Zhang. (1999) Effect of Yunqi decoction on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients) on esophageal mucosal morphology and esophageal motility in reflux esophagitis patients. Chinese Journal of Integrative Medicine 5:1, pages 32-35.
Crossref
Mark SteinMani Kavuru & Joel Richter. 1999. Gastroesophageal Reflux Disease and Airway Disease. Gastroesophageal Reflux Disease and Airway Disease 179 207 .
L. Okolicsanyi & C. Guatti-Zuliani. 1999. Pneumological Aspects of Gastroesophageal Reflux. Pneumological Aspects of Gastroesophageal Reflux 175 191 .
Lars Lundell & John Dent. 1999. Proton Pump Inhibitors. Proton Pump Inhibitors 223 235 .
Sharma, Ugheoke, Vasudeva & Howden. (2001) The pharmacodynamics of lansoprazole administered via gastrostomy as intact, non‐encapsulated granules. Alimentary Pharmacology & Therapeutics 12:11, pages 1171-1174.
Crossref
Geus, Mulder, Nicolai, D. M. Van Den Boomgaard & Lamers. (2001) Acid‐inhibitory effects of omeprazole and lansoprazole in Helicobacter pylori ‐negative healthy subjects . Alimentary Pharmacology & Therapeutics 12:4, pages 329-335.
Crossref
J. M. Lee & C. A. O'Morain. (1998) Trends in the management of gastro-oesophageal reflux disease.. Postgraduate Medical Journal 74:869, pages 145-150.
Crossref
Jaspersen, Diehl, Schoeppner, Geyer & Martens. (2001) A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis. Alimentary Pharmacology & Therapeutics 12:1, pages 49-52.
Crossref
John M. Wo & J. Patrick Waring. (1997) MEDICAL THERAPY OF GASTROESOPHAGEAL REFLUX AND MANAGEMENT OF ESOPHAGEAL STRICTURES. Surgical Clinics of North America 77:5, pages 1041-1062.
Crossref
R. Carlsson, J.‐P. Galmiche, J. Dent, L. Lundell & L. Frison. (2003) Prognostic factors influencing relapse of oesophagitis during maintenance therapy with antisecretory drugs: a meta‐analysis of long‐term omeprazole trials. Alimentary Pharmacology & Therapeutics 11:3, pages 473-482.
Crossref
Anthony E. Zimmermann & Brian G. Katona. (2012) Lansoprazole: A Comprehensive Review. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 17:2, pages 308-326.
Crossref
S. J. SONTAG, T. G. SCHNELL, G. CHEJFEC, C. KURUCAR, J. KARPF & G. LEVINE. (1997) Lansoprazole heals erosive reflux oesophagitis in patients with Barrett's oesophagus. Alimentary Pharmacology and Therapeutics 11:1, pages 147-156.
Crossref
J. S. A. Collins. (1996) Medical Management of Gastro-oesophageal Reflux Disease. Irish Journal of Medical Science 165:3, pages 191-192.
Crossref
Vasilios A Skoutakis, Ronald H Joe & Dimitri S Hara. (2016) Comparative Role of Omeprazole in The Treatment of Gastroesophageal Reflux Disease. Annals of Pharmacotherapy 29:12, pages 1252-1262.
Crossref
O Chassany, D Elkharrat, JF Bergmann & JM Segrestaa. (1995) Principes thérapeutiques du reflux gastroœsophagien. La Revue de Médecine Interne 16:12, pages 960-970.
Crossref
K. D. BARDHAN. (2008) The role of proton pump inhibitors in the treatment of gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 9, pages 15-25.
Crossref
R. H. HUNT. (2008) The relationship between the control of pH and healing and symptom relief in gastro-oesophageal reflux disease. Alimentary Pharmacology & Therapeutics 9, pages 3-7.
Crossref
Rosemary R. Berardi & Lynda S. Welage. (2016) Current Status of Gastric Proton Pump Inhibitors in the Treatment of Acid-Peptic Disease. Journal of Pharmacy Practice 7:4, pages 165-176.
Crossref
W. A. De BOER & G. N. J. TYTGAT. (2007) Review article: drug therapy for reflux oesophagitis. Alimentary Pharmacology & Therapeutics 8:2, pages 147-157.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.